Table 1.
Scoring of Multimodal cSLO Imaging Biomarkers
| Score | ||||||
|---|---|---|---|---|---|---|
| Objective | Mode | Imaging biomarker | 3 | 2 | 1 | 0 |
| Graft | SWF | Size | 20 < ∼ ≤ 100 | 5 ≤ ∼ ≤ 20 | 0 < ∼ < 5 | 0 |
| Intensity | 3 ≤ | 1.5 ≤ ∼ < 3 | 0 < ∼ < 1.5 | 0 | ||
| SD-OCT | Length | 10 < | 5≤ ∼ ≤ 10 | 0 < ∼ < 5 | 0 | |
| Placement | NA | NA | On-target | Off-target | ||
| Lamination | NA | NA | Yes | No | ||
| Complications | MR | Hemorrhage | 0 | 0 < ∼ < 10 | 10 ≤ ∼ ≤ 50 | 50 < ∼ ≤ 100 |
| SD-OCT | Retinal atrophy | 100 ≤ | 65 < ∼ < 100 | 30 ≤ ∼ ≤ 65 | 0 ≤ ∼ < 30 | |
| Both | Peri-retinal proliferation | None | Vitreous haze | Membrane | Retinal detachment | |
Imaging biomarkers were developed from multimodal imaging modes to describe graft status and recipient complications. For grafts, SWF imaging data indicated fluorescent size and intensity. SD-OCT imaging presented graft length, graft placement, and intragraft lamination. For complications, MR imaging presented the hemorrhage. SD-OCT imaging detected the retinal atrophy. The periretinal proliferation was manually determined based on MR and SD-OCT image (“both” above) data. The scores of 0 to 3 were applied for each imaging biomarker as appropriate. NA, not applicable.